Previous close | 6.47 |
Open | 6.00 |
Bid | 4.90 |
Ask | 7.60 |
Strike | 47.00 |
Expiry date | 2024-06-21 |
Day's range | 6.00 - 6.47 |
Contract range | N/A |
Volume | |
Open interest | 11 |
PHILADELPHIA, June 07, 2024--US FDA approves expanded age indication for GSK’s AREXVY, the first respiratory syncytial virus (RSV) vaccine for adults aged 50-59 at increased risk
We recently compiled a list of 20 Cities With the Highest HIV/AIDS Rates in the US and in this article, we will talk about the city with the highest HIV/AIDS rates in the US. HIV Incidence and Prevalence in the United States The government of the United States has set a goal to reduce the […]
The simplest way to invest in stocks is to buy exchange traded funds. But one can do better than that by picking better...